|
|
||||||||||
|
J Am Coll Cardiol, 2000; 36:1173-1177 © 2000 by the American College of Cardiology Foundation |
a Department of Cardiac Surgery, Medical University of Luebeck, Luebeck, Germany
Manuscript received August 6, 1999; revised manuscript received March 16, 2000, accepted April 28, 2000.
Reprint requests and correspondence: Prof. Dr. Hans-H. Sievers, Department of Cardiac Surgery, Medical University of Luebeck, Ratzeburger Allee 160, D-23538 Luebeck, Germany
schmidtk{at}medinf.mu-luebeck.de
OBJECTIVES
The objective of this study was to compare the outcome of patients >60 years of age with younger patients after the Ross procedure.
BACKGROUND
Currently, the Ross procedure is performed predominantly in young patients. Main arguments against the Ross procedure in the elderly are the complexity of the operation and related risks. Experience with the Ross procedure in patients >60 years of age is scarce.
METHODS
Between February 1990 and August 1998, the Ross procedure was performed in 27 patients (15 men and 12 women) >60 years of age (mean 64.2 ± 3.1 years, range 60.5 to 70.6; group A) and in 84 patients (68 men, 12 women) <60 years of age (mean 43.8 ± 12.4 years, range 15.2 to 59.4; group B). Echocardiography was applied at a mean follow-up of 28.4 ± 21.0 and 25.2 ± 21.4 months, respectively, to determine hemodynamic variables (ejection fraction, fractional shortening, stroke volume, cardiac output), cardiac dimensions and autograft and homograft valve function.
RESULTS
There was one early and one late (esophageal bleeding) death in group B; the mortality rate was 0% in group A. One autograft was replaced because of a subvalvular aneurysm, and one patient was lost to follow-up (group B). There were no significant differences in cardiac dimensions, grade of insufficiencies across homografts and autografts and hemodynamic variables, except for a higher pressure gradient across the homograft in group B (maximal pressure gradient 11.3 ± 5.6 vs. 7.7 ± 4.6 mm Hg in group A). The median New York Heart Association functional class was I in both groups.
CONCLUSIONS
Our seven years of experiences (mean follow-up 28 months) indicate that the Ross procedure may be performed in selected patients >60 years of age without increased risk for mortality or complications in experienced centers.
| ||||||||||||
This article has been cited by other articles:
![]() |
M. Salehi, R. Sattarzadeh, A. A. Soleimani, H. Radmehr, J. Mirhosseini, and M. Sanatkar Far The Ross Operation: Clinical Results and Echocardiographic Findings Asian Cardiovasc Thorac Ann, February 1, 2007; 15(1): 30 - 34. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Concha, G. Pradas, A. Juffe, J. M. Caffarena, A. Montero, and P. J. Aranda Comprehensive experience with the Ross operation in Spain Eur. J. Cardiothorac. Surg., October 1, 2003; 24(4): 521 - 526. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. O. Bohm, C. A. Botha, W. Hemmer, C. Starck, G. Blumenstock, D. Roser, and J.-G. Rein Older patients fare better with the Ross operation Ann. Thorac. Surg., March 1, 2003; 75(3): 796 - 801. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.F. M. Bechtel, C. Bartels, C. Schmidtke, W. Skibba, M. Muller-Steinhardt, H. Kluter, and H.-H. Sievers Does Histocompatibility Affect Homograft Valve Function After the Ross Procedure? Circulation, September 18, 2001; 104(90001): I-25 - 28. [Abstract] [Full Text] [PDF] |
||||
| HOME | SUBSCRIPTIONS | CURRENT ISSUE | PAST ISSUES | CARDIOSOURCE | SEARCH | HELP | FEEDBACK |